Your browser doesn't support javascript.
loading
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
O'Reilly, Joseph E; Blackbourn, Luke A K; Caparrotta, Thomas M; Jeyam, Anita; Kennon, Brian; Leese, Graham P; Lindsay, Robert S; McCrimmon, Rory J; McGurnaghan, Stuart J; McKeigue, Paul M; McKnight, John A; Petrie, John R; Philip, Sam; Sattar, Naveed; Wild, Sarah H; Colhoun, Helen M.
Afiliação
  • O'Reilly JE; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK.
  • Blackbourn LAK; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK.
  • Caparrotta TM; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK.
  • Jeyam A; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK.
  • Kennon B; Queen Elizabeth University Hospital, Glasgow, UK.
  • Leese GP; Ninewells Hospital, Dundee, UK.
  • Lindsay RS; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • McCrimmon RJ; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
  • McGurnaghan SJ; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK.
  • McKeigue PM; Usher Institute of Population Health Sciences and Informatics, Centre for Population Health Sciences, School of Molecular, Genetic and Population Health Sciences, University of Edinburgh, Edinburgh, UK.
  • McKnight JA; Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Petrie JR; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Philip S; Grampian Diabetes Research Unit, Diabetes Centre, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Wild SH; Usher Institute of Population Health Sciences and Informatics, Centre for Population Health Sciences, School of Molecular, Genetic and Population Health Sciences, University of Edinburgh, Edinburgh, UK.
  • Colhoun HM; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XUT, UK. helen.colhoun@igmm.ed.ac.uk.
Diabetologia ; 63(8): 1626-1636, 2020 08.
Article em En | MEDLINE | ID: mdl-32451572
AIMS/HYPOTHESIS: We aimed to examine whether crude mortality and mortality relative to the general population below 50 years of age have improved in recent years in those with type 1 diabetes. METHODS: Individuals with type 1 diabetes aged below 50 and at least 1 year old at any time between 2004 and 2017 in Scotland were identified using the national register. Death data were obtained by linkage to Scottish national death registrations. Indirect age standardisation was used to calculate sex-specific standardised mortality ratios (SMRs). Poisson regression was used to test for calendar-time effects as incidence rate ratios (IRRs). RESULTS: There were 1138 deaths in 251,143 person-years among 27,935 people with type 1 diabetes. There was a significant decline in mortality rate over time (IRR for calendar year 0.983 [95% CI 0.967, 0.998], p = 0.03), but the SMR remained approximately stable at 3.1 and 3.6 in men and 4.09 and 4.16 in women for 2004 and 2017, respectively. Diabetic ketoacidosis or coma (DKAoC) accounted for 22% of deaths and the rate did not decline significantly (IRR 0.975 [95% CI 0.94, 1.011], p = 0.168); 79.3% of DKAoC deaths occurred out of hospital. Circulatory diseases accounted for 27% of deaths and did decline significantly (IRR 0.946 [95% CI 0.914, 0.979], p = 0.002). CONCLUSIONS/INTERPRETATION: Absolute mortality has fallen, but the relative impact of type 1 diabetes on mortality below 50 years has not improved. There is scope to improve prevention of premature circulatory diseases and DKAoC and to develop more effective strategies for enabling people with type 1 diabetes to avoid clinically significant hyper- or hypoglycaemia. Graphical abstract.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article